176 related articles for article (PubMed ID: 12220031)
1. Prognosis following surgical excision of canine cutaneous mast cell tumors with histopathologically tumor-free versus nontumor-free margins: a retrospective study of 31 cases.
Michels GM; Knapp DW; DeNicola DB; Glickman N; Bonney P
J Am Anim Hosp Assoc; 2002; 38(5):458-66. PubMed ID: 12220031
[TBL] [Abstract][Full Text] [Related]
2. Recurrence rates and sites for grade II canine cutaneous mast cell tumors following complete surgical excision.
Weisse C; Shofer FS; Sorenmo K
J Am Anim Hosp Assoc; 2002; 38(1):71-3. PubMed ID: 11804319
[TBL] [Abstract][Full Text] [Related]
3. Impact of tumour depth, tumour location and multiple synchronous masses on the prognosis of canine cutaneous mast cell tumours.
Kiupel M; Webster JD; Miller RA; Kaneene JB
J Vet Med A Physiol Pathol Clin Med; 2005 Aug; 52(6):280-6. PubMed ID: 16050909
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous mast cell tumors in cats: 32 cases (1991-1994).
Molander-McCrary H; Henry CJ; Potter K; Tyler JW; Buss MS
J Am Anim Hosp Assoc; 1998; 34(4):281-4. PubMed ID: 9657159
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a two-centimeter lateral surgical margin for excision of grade I and grade II cutaneous mast cell tumors in dogs.
Fulcher RP; Ludwig LL; Bergman PJ; Newman SJ; Simpson AM; Patnaik AK
J Am Vet Med Assoc; 2006 Jan; 228(2):210-5. PubMed ID: 16426187
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of prognostic factors associated with outcome in dogs with multiple cutaneous mast cell tumors treated with surgery with and without adjuvant treatment: 54 cases (1998-2004).
Mullins MN; Dernell WS; Withrow SJ; Ehrhart EJ; Thamm DH; Lana SE
J Am Vet Med Assoc; 2006 Jan; 228(1):91-5. PubMed ID: 16426175
[TBL] [Abstract][Full Text] [Related]
7. Biologic behavior and prognostic factors for mast cell tumors of the canine muzzle: 24 cases (1990-2001).
Gieger TL; Théon AP; Werner JA; McEntee MC; Rassnick KM; DeCock HE
J Vet Intern Med; 2003; 17(5):687-92. PubMed ID: 14529136
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical and clinical evaluation of p53 in canine cutaneous mast cell tumors.
Jaffe MH; Hosgood G; Taylor HW; Kerwin SC; Hedlund CS; Lopez MK; Davidson JR; Miller DM; Paranjpe M
Vet Pathol; 2000 Jan; 37(1):40-6. PubMed ID: 10643979
[TBL] [Abstract][Full Text] [Related]
9. Relationships between the histological grade of cutaneous mast cell tumours in dogs, their survival and the efficacy of surgical resection.
Murphy S; Sparkes AH; Smith KC; Blunden AS; Brearley MJ
Vet Rec; 2004 Jun; 154(24):743-6. PubMed ID: 15224593
[TBL] [Abstract][Full Text] [Related]
10. Results of radiation therapy in 19 dogs with cutaneous mast cell tumor and regional lymph node metastasis.
Chaffin K; Thrall DE
Vet Radiol Ultrasound; 2002; 43(4):392-5. PubMed ID: 12175005
[TBL] [Abstract][Full Text] [Related]
11. The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors.
Kiupel M; Webster JD; Kaneene JB; Miller R; Yuzbasiyan-Gurkan V
Vet Pathol; 2004 Jul; 41(4):371-7. PubMed ID: 15232137
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcome of dogs with grade-II mast cell tumors treated with surgery alone: 55 cases (1996-1999).
Séguin B; Leibman NF; Bregazzi VS; Ogilvie GK; Powers BE; Dernell WS; Fettman MJ; Withrow SJ
J Am Vet Med Assoc; 2001 Apr; 218(7):1120-3. PubMed ID: 11318363
[TBL] [Abstract][Full Text] [Related]
13. Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs.
Patnaik AK; Ehler WJ; MacEwen EG
Vet Pathol; 1984 Sep; 21(5):469-74. PubMed ID: 6435301
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors for survival of dogs with inguinal and perineal mast cell tumors treated surgically with or without adjunctive treatment: 68 cases (1994-2002).
Cahalane AK; Payne S; Barber LG; Duda LE; Henry CJ; Mauldin GE; Frimberger AE; Cotter SM; Moore AS
J Am Vet Med Assoc; 2004 Aug; 225(3):401-8. PubMed ID: 15328716
[TBL] [Abstract][Full Text] [Related]
15. Outcome of dogs with mast cell tumors in the inguinal or perineal region versus other cutaneous locations: 124 cases (1990-2001).
Sfiligoi G; Rassnick KM; Scarlett JM; Northrup NC; Gieger TL
J Am Vet Med Assoc; 2005 Apr; 226(8):1368-74. PubMed ID: 15844431
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of radiation therapy for incompletely resected grade-III mast cell tumors in dogs: 31 cases (1987-1998).
Hahn KA; King GK; Carreras JK
J Am Vet Med Assoc; 2004 Jan; 224(1):79-82. PubMed ID: 14710881
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of surgical margins required for complete excision of cutaneous mast cell tumors in dogs.
Simpson AM; Ludwig LL; Newman SJ; Bergman PJ; Hottinger HA; Patnaik AK
J Am Vet Med Assoc; 2004 Jan; 224(2):236-40. PubMed ID: 14736068
[TBL] [Abstract][Full Text] [Related]
18. Radiation therapy for incompletely resected canine mast cell tumors.
LaDue T; Price GS; Dodge R; Page RL; Thrall DE
Vet Radiol Ultrasound; 1998; 39(1):57-62. PubMed ID: 9491519
[TBL] [Abstract][Full Text] [Related]
19. Iridium-192 interstitial brachytherapy as adjunctive treatment for canine cutaneous mast cell tumors.
Northrup NC; Roberts RE; Harrell TW; Allen KL; Howerth EW; Gieger TL
J Am Anim Hosp Assoc; 2004; 40(4):309-15. PubMed ID: 15238561
[TBL] [Abstract][Full Text] [Related]
20. Effects of stage and number of tumours on prognosis of dogs with cutaneous mast cell tumours.
Murphy S; Sparkes AH; Blunden AS; Brearley MJ; Smith KC
Vet Rec; 2006 Mar; 158(9):287-91. PubMed ID: 16517820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
